USPTO serial 79075435
Serial No. 79075435
Reviewed by CopyMark Law Group
Reg. 3960665Status 404
- Filing date
- Status date
- Registration date
- May 17, 2011
- Examiner
- HELLMAN, ELI J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79075435?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals for use in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals or pharmaceutical development candidates for treating infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemicals for use in the manufacture of medical and scientific preparations; nucleotides, nucleotide analogues and oligonucleotides for medical research and development | SECTION 71 - CANCELLED | — |
| 005 | pharmaceutical preparations for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemical preparations for pharmaceutical, medical and therapeutic purposes, namely, for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system autoimmune diseases, genetic disorders and malignant diseases | SECTION 71 - CANCELLED | — |
| 042 | scientific and technological services, namely, biopharmaceutical research as well as research and design connected thereto, namely, design and development of pharmaceutical products, biomedical and biotechnological analysis and research; development of medical and biomedical products and preparations; biochemical and molecular biological analysis; scientific, biotechnological and biomedical consultancy; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical preparations, methods and products | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Santaris Pharma A/S
- Other trademarks owned by Santaris Pharma A/S
- Other trademarks owned by Santaris Pharma A/S
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 6, 2020 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Mar 6, 2020 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 7, 2018 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 10, 2018 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 10, 2018 | INPC | INVALIDATION PROCESSED | — |
| Aug 22, 2018 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 22, 2017 | C71T | CANCELLED SECTION 71 | — |
| Nov 7, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 24, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 6, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 5, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 17, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 17, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 1, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 9, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 25, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 21, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 22, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2010 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 29, 2010 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 11, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 11, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 11, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2010 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 18, 2010 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 22, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 11, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 11, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 11, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 10, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 9, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 7, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 4, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |